Tech Times on MSN
CAR-T cell therapy delivers drug-free remissions in treatment-resistant lupus and arthritis, three studies find
CAR-T cell therapy autoimmune disease trials at ACR Convergence 2026 showed drug-free remissions in treatment-resistant lupus ...
MedPage Today on MSN
CAR-T therapy: Mixed results in rheumatoid arthritis trial
Six patients treated: three show strong responses, three not so much ...
Severe early thrombocytopenia following CAR T-cell therapy is associated with reduced overall survival and higher relapse ...
An off-the-shelf CAR T-cell therapy shows encouraging early safety and substantial B-cell depletion in progressive MS, ...
RMAT designation provides early and frequent FDA engagement to support planned pivotal development of Senza5 CART5 Therapy ...
As CAR-T therapies continue to evolve, improved care coordination, earlier patient referrals and enhanced support systems can help more patients successfully navigate the journey to treatment ...
A multicenter clinical trial evaluating chimeric antigen receptor-T cell therapy (CAR-T cell therapy) for stiff person ...
New ACR 2026 data highlight CAR T-cell therapy remissions in refractory arthritis and patient priorities in lupus. Read more ...
An experimental treatment has kept one patient with heavily pretreated hairy cell leukemia free of detectable disease for ...
A type of cellular therapy originally developed to treat cancer is showing promise as a potential treatment for people with ...
I f your doctor has recommended chimeric antigen receptor (CAR) T-cell immunotherapy for large B-cell lymphoma (LBCL), you’ve likely already tried several standard treatments, and the cancer did not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results